文献速递功能神经外科

微创三叉神经消融:经口入路靶向治疗V3区三叉神经痛的新技术

Minimally Invasive Trigeminal Ablation: Novel Transoral Technique for Targeted Treatment of V3.
PubMed 文献 · World Neurosurg · 2018-07-19

本文报告一例6年病史、药物难治且拒绝立体定向放射外科的三叉神经痛患者,采用内镜下经口微创三叉神经消融术治疗。术后16周疼痛完全缓解,仅遗留轻微感觉神经性麻木。作者认为内镜经口入路可精准靶向特定神经分布区,为首次报道。

要点

  • 内镜下经口微创入路可用于三叉神经V3分布区疼痛的消融治疗。
  • 本例术后16周疼痛完全缓解,仅遗留轻微感觉神经性麻木。
  • 作者称此为首次报道的内镜经口微创三叉神经消融病例。

核心结论

  • 内镜入路通过视觉引导实现精准靶向,适合针对特定神经分布区疼痛行神经消融的患者。
  • 作者称这是首例报道的内镜经口微创入路用于三叉神经痛消融治疗。

研究设计与样本

  • 个案报告:一例6年病史、药物治疗抵抗且拒绝立体定向放射外科的三叉神经痛患者,接受微创三叉神经消融术。

主要发现

  • 患者术后16周报告疼痛完全缓解,仅遗留轻微感觉神经性麻木。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Trigeminal neuralgia (TN) is a chronic orofacial pain syndrome that presents with debilitating shooting pains in the V3 nerve distribution. The condition is traditionally responsive to anticonvulsant therapy; however, cases that become refractory to medications often require surgical intervention. CASE DESCRIPTION: We present a case of TN that was treated with minimally invasive trigeminal ablation. The patient presented with a 6-year history of TN that had been resistant to medical management. The patient opted for minimally invasive management, refused stereotactic radiosurgery, and was treated using the minimally invasive trigeminal ablation approach. At 16 weeks postoperatively, the patient reported complete alleviation of pain with minimal sensorineural numbness. CONCLUSIONS: The endoscopic approach allows for precise targeting through visual guidance, which is ideal in patients undergoing neuroablation for pain within specific nerve distributions. This is the first documented case of an endoscopic minimally invasive transoral approach toward ablative TN management.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ashman P, Ward M, Umanoff M, et al. Minimally Invasive Trigeminal Ablation: Novel Transoral Technique for Targeted Treatment of V3. World Neurosurg. 2018. PMID: 30031955. doi:10.1016/j.wneu.2018.07.098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。